Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 411-420 of 1153 total displayed.

Past content (since Jan 1999):

Molecular Cardiology
Gelatin Hydrogel Microspheres Enable Pinpoint Delivery of Basic Fibroblast Growth Factor for the Development of Functional Collateral Vessels
Akihiro Hosaka, Hiroyuki Koyama, Toshihiro Kushibiki, Yasuhiko Tabata, Nobuhiro Nishiyama, Tetsuro Miyata, Hiroshi Shigematsu, Tsuyoshi Takato, and Hirokazu Nagawa
Circulation 2004;110:3322-3328; published online before print as doi:10.1161/01.CIR.0000147779.17602.18 [Abstract] [Full text]  

Articles
Control of Plasma Nitric Oxide Bioactivity by Perfluorocarbons. Physiological Mechanisms and Clinical Implications
Olga Rafikova, Elena Sokolova, Ruslan Rafikov, and Evgeny Nudler
Circulation published November 22, 2004, doi:10.1161/01.CIR.0000148782.37563.F8 [Abstract]  

New Drugs and Technologies
Which Inhibitor of the Renin–Angiotensin System Should Be Used in Chronic Heart Failure and Acute Myocardial Infarction?
John J.V. McMurray, Marc A. Pfeffer, Karl Swedberg, and Victor J. Dzau
Circulation 2004;110:3281-3288, doi:10.1161/01.CIR.0000147274.83071.68 [Full text]  

New Drugs and Technologies
Cardiovascular Effects of the 3 Phosphodiesterase-5 Inhibitors Approved for the Treatment of Erectile Dysfunction
Robert A. Kloner
Circulation 2004;110:3149-3155, doi:10.1161/01.CIR.0000146906.42375.D3 [Full text]  

Articles
Placebo-Controlled, Randomized Clinical Trial of Azimilide for Prevention of Ventricular Tachyarrhythmias in Patients With an Implantable Cardioverter Defibrillator
Paul Dorian, Martin Borggrefe, Hussein R. Al-Khalidi, Stefan H. Hohnloser, Jose M. Brum, Daljit S. Tatla, Johannes Brachmann, Robert J. Myerburg, David S. Cannom, Michael van der Laan, Michael J. Holroyde, Igor Singer, Craig M. Pratt on Behalf of the SHock Inhibition Evaluation with azimiLiDe (SHIELD) Investigators
Circulation published November 8, 2004, doi:10.1161/01.CIR.0000149240.98971.A8 [Abstract]  

Arrhythmia/Electrophysiology
Acute ß-Blockade Increases Muscle Sympathetic Activity and Modifies Its Frequency Distribution
Chiara Cogliati, Simona Colombo, Tomaso Gnecchi Ruscone, Domenico Gruosso, Alberto Porta, Nicola Montano, Alberto Malliani, and Raffaello Furlan
Circulation 2004;110:2786-2791; published online before print as doi:10.1161/01.CIR.0000146335.69413.F9 [Abstract] [Full text]  

Coronary Heart Disease
Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria
Folkert W. Asselbergs, Gilles F.H. Diercks, Hans L. Hillege, Ad J. van Boven, Wilbert M.T. Janssen, Adriaan A. Voors, Dick de Zeeuw, Paul E. de Jong, Dirk J. van Veldhuisen, Wiek H. van Gilst for the Prevention of Renal and Vascular Endstage Disease Intervention Trial Investigators
Circulation 2004;110:2809-2816; published online before print as doi:10.1161/01.CIR.0000146378.65439.7A [Abstract] [Full text]  

Vascular Medicine
Anti–Glycoprotein VI Treatment Severely Compromises Hemostasis in Mice With Reduced {alpha}2ß1 Levels or Concomitant Aspirin Therapy
Sabine Grüner, Miroslava Prostredna, Barsom Aktas, Alexandra Moers, Valerie Schulte, Thomas Krieg, Stefan Offermanns, Beate Eckes, and Bernhard Nieswandt
Circulation 2004;110:2946-2951; published online before print as doi:10.1161/01.CIR.0000146341.63677.3C [Abstract] [Full text]  

Articles
Gelatin Hydrogel Microspheres Enable Pinpoint Delivery of Basic Fibroblast Growth Factor for the Development of Functional Collateral Vessels
Akihiro Hosaka, Hiroyuki Koyama, Toshihiro Kushibiki, Yasuhiko Tabata, Nobuhiro Nishiyama, Tetsuro Miyata, Hiroshi Shigematsu, Tsuyoshi Takato, and Hirokazu Nagawa
Circulation published November 1, 2004, doi:10.1161/01.CIR.0000147779.17602.18 [Abstract]  

Cardiovascular Surgery
Clinical Inhibition of the Seven-Transmembrane Thrombin Receptor (PAR1) by Intravenous Aprotinin During Cardiothoracic Surgery
J.R.S. Day, P.P. Punjabi, A.M. Randi, D.O. Haskard, R.C. Landis, and K.M. Taylor
Circulation 2004;110:2597-2600; published online before print as doi:10.1161/01.CIR.0000138027.80056.31 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment